TG Therapeutics | TGTX - Kapitał Własny I Rezerwy





Kapitał Własny I Rezerwy Zmiana Data
AbbVie USD -5.94B 721M 2026-06
Alaunos Therapeutics USD 1.29M 865K 2026-03
Amgen USD 11.69B 2.5B 2026-06
Ardelyx USD 148.62M 18.33M 2026-03
Arrowhead Research USD 465.53M 148.45M 2026-06
Bayer EUR 28.85B 2.9B 2026-03
Biogen USD 18.85B 196.3M 2026-06
Corcept Therapeutics USD 705.78M 67.79M 2026-06
Curis USD 12.71M 7.24M 2026-03
Gilead Sciences USD 11.74B 11.77B 2026-06
J&J USD 84.97B 3.78B 2026-06
Karyopharm Therapeutics USD -265.65M 27.28M 2026-03
Novartis USD 41.95B 3.02B 2026-06
Novavax USD -190.71M 45.94M 2026-06
PTC Therapeutics USD -165.36M 15.1M 2026-06
Puma Biotechnology USD 115.27M 10.55M 2025-09
Regeneron Pharmaceuticals USD 31.71B 287.8M 2026-06
Roche Holding CHF 32.69B 1.11B 2026-06
TG Therapeutics USD 604.08M 20.95M 2026-06
Verastem USD 81.78M 24.58M 2026-03
Vertex Pharmaceuticals USD 20.25B 886M 2026-06